MNTA—Slide #23 from today’s Eliquis presentation suggests that Eliquis will not be submitted for FDA approval in VTE prevention in the near future (and perhaps not ever). This is consistent with the competitive analysis in paragraph ‘A’ of #msg-64862315.
Market Data 
Markets 
AI
